pipette
ENEnglish

FKS1/2-variant independent mechanisms underlying the emergence of resistance in echinocandin-refractory Candida auris infections

Hugh Gifford, Arnab Pradhan, Ben A Caswall, Sarah E. Murphy, Ian Leaves, Matt B. Edmondson, Tanmoy Chakraborty, Duncan Wilson, Surabhi K. Taori, Neil A. R. Gow, Rhys A. Farrer, Alistair J. P. Brown, Tihana A. Bicanic

Revista con revisión por paresUso en el mundo real

En palabras de los autores

Abstract The emerging fungus Candida auris is a drug resistant global public health threat and WHO critical priority pathogen. Recommended first-line invasive candidiasis treatment is echinocandin monotherapy, but C. auris can develop on-treatment resistance via FKS1/2 gene mutations and additional, previously unexplained mechanisms. To better understand echinocandin failure in C. auris , we sequenced the genomes of echinocandin refractory FKS1/2 wild-type C. auris serial isolates from two critically unwell patients in London, UK. Population analysis profiling revealed echinocandin heteroresistance, and in vitro culture of clinical isolates at supra-MIC concentrations of anidulafungin (8 μg/ml) exhibited morphotypic heterogeneity. Small colony variants (SCVs) and large colony variants (LCVs) showed elevated MICs with polyploidy (to 4n and above) alongside adaptive changes in cell wall β−1,3-glucan content. LCVs contained significantly more mutations in calcineurin-related stress tolerance pathway gene CRZ1 compared to clinical parents and SCVs, associated with further increases in MIC. These findings indicate progressive step-wise accrual of adaptation to echinocandins, including genomic instability, alterations in stress tolerance pathways, and cell wall remodelling, paving the way for resistance emergence.

Resultado principalEl resumen no menciona limitaciones.

Apareció: sábado, 17 de octubre. Nature Communications. Revista con revisión por pares.

DOI: 10.1038/s41467-026-76954-x